Valcon Medical A/S
CVR 40086714 · Public limited company (A/S) · Active · Low risk
Valcon Medical A/S is a Public limited company (A/S), founded on , based in Lynge. The company is registered in the industry fremstilling af andre organiske basiskemikalier. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 7 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 11.4m and a net result of DKK -11.2m.
Bankruptcy risk for Valcon Medical A/S
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40086714
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (7 years)
- Address
- Industrivej 12
3540 Lynge - Municipality
- Allerød
- Industry
- Fremstilling af andre organiske basiskemikalier (201400)
Bankruptcies in the industry: Fremstilling af parfume, hårshampoo, tandpasta mv. - Share capital
- DKK 27.2m
- Employees
- 0 (2018)
- Auditor
- CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 7 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 40.5% |
| Current ratio | 106% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 2.1m | DKK -28.2m | DKK -15.1m |
| Net profit | DKK -11.2m | DKK -41.7m | DKK -30.3m |
| Equity | DKK 11.4m | DKK 1.2m | DKK 38.7m |
| Total assets | DKK 28.2m | DKK 26.9m | DKK 50.3m |
| Cash | DKK 1.2m | DKK 29k | – |
| Short-term debt | DKK 12.0m | DKK 15.3m | – |
| Avg. employees | 12 | 14 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Crowe.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 131 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 182 | ||
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 175 | ||
| 1 Jan 2020 – 31 Dec 2020 | 180 | ||
| 13 Dec 2018 – 31 Dec 2019 | 244 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Emil Guldmann Sigetty | ||
| Board | William Muecke | Current | |
| Board | Ruchir Ashok Kadakia | Current | |
| Board | Alex Sung Kwon | Current | |
| Board | Douglas Fischer | Current | |
| Board | Mike Steen Hansen | ||
| Board | Farzad Jahanshahi | ||
| Board | Peter Emil Guldmann Sigetty | ||
| Board | Pete Patterson | ||
| Board | NELSON CAMARGO CURY | ||
| Board | Joel David Sherlock | ||
| Board | Mike Steen Hansen | ||
| Board | Joel David Sherlock | ||
| Board | William Muecke | ||
| Board | Diego Francisco Gomez Dueñas | ||
| Board | E Stanton Mclean | ||
| Board | Joel David Sherlock | ||
| Board | William Muecke | ||
| Board | Pete Patterson | ||
| Owner (67%) | BTS DK ApS | Current | |
| Owner (25%) | Medican A/S | ||
| Owner (5%) | PESI Holding ApS | ||
| Owner (25%) | Cannabis Science Invest ApS | ||
| Owner (10%) | 1187243 B.C.Ltd. | ||
| Owner (20%) | Medican A/S | ||
| Owner (5%) | Cannabis Science Invest ApS | ||
| Owner (15%) | GREENFIELD GLOBAL OPPORTUNITIES FUND LIMITED PARTNERSHIP | ||
| Owner (5%) | Valcon Medical A/S | ||
| Owner (25%) | Artemis Founders Investments, LLC | ||
| Owner (5%) | PESI Holding ApS | ||
| Owner (15%) | 1187243 B.C.Ltd. | ||
| Owner (10%) | GREENFIELD GLOBAL OPPORTUNITIES FUND LIMITED PARTNERSHIP | ||
| Owner (10%) | 1187243 B.C.Ltd. | ||
| Owner (15%) | Artemis Accelerator Fund LLC | ||
| Owner (5%) | 1187243 B.C.Ltd. | ||
| Owner (5%) | 1187243 B.C.Ltd. | ||
| Owner (5%) | Artemis Founders Investments, LLC | ||
| Auditor | CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB | Current | |
| Founder | Medican A/S | Current | |
| Founder | PESI Holding ApS | Current | |
| Founder | Cannabis Science Invest ApS | Current | |
| Founder | 1187243 B.C.Ltd. | Current |
The CEOs' other companies
Peter Emil Guldmann Sigetty – 3 other companies, of which 1 bankrupt
- Medican A/S Bankrupt 15 Aug 2023
- FPP ApS Opløst
- Scanleaf ApS Fusioneret
Address history (1 moves)
| Industrivej 12, 3540 Lynge | |
| Olfert Fischers Gade 26, 1311 København K |
Former names
| Valcon Medical A/S | – now |
| Aureum A/S | – |
Employees per year
Other companies at the same address
- BIFO INVEST A/S Fusioneret
- BIFO-TRADING ApS Opløst
- BIFOPET PRODUCT A/S Opløst
Questions and answers about Valcon Medical A/S
Has Valcon Medical A/S gone bankrupt?
No, Valcon Medical A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Valcon Medical A/S?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the auditor of Valcon Medical A/S?
Valcon Medical A/S most recently used CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB.
When was Valcon Medical A/S founded?
Valcon Medical A/S was founded on 13 December 2018.
What is the equity of Valcon Medical A/S?
Equity was DKK 11.4m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.